Determination of glucose-6-phosphate dehydrogenase cut-off values in a Tunisian population
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the commonest enzymopathy worldwide. The incidence depends essentially on the methods used for the assessment. In this respect, we attempted in this study to set cut-off values of G6PD activity to discriminate among normal, heterozygous, and def...
Saved in:
Published in | Clinical chemistry and laboratory medicine Vol. 55; no. 8; pp. 1193 - 1201 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Germany
De Gruyter
26.07.2017
Walter De Gruyter & Company |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the commonest enzymopathy worldwide. The incidence depends essentially on the methods used for the assessment. In this respect, we attempted in this study to set cut-off values of G6PD activity to discriminate among normal, heterozygous, and deficient individuals using the World Health Organization (WHO) classification and the receiver operating characteristics (ROC) curve analysis.
Blood samples from 250 female and 302 male subjects were enrolled in this study. The G6PD activity was determined using a quantitative assay. The common G6PD mutations in Tunisia were determined using the amplification refractory mutation system (ARMS-PCR) method. The ROC curve was used to choice the best cut-off.
Normal G6PD values were 7.69±2.37, 7.86±2.39, and 7.51±2.35 U/g Hb for the entire, male, and female groups, respectively. Cut-off values for the total, male, and female were determined using the WHO classification and ROC curves analysis. In the male population, both cut-offs established using ROC curve analysis (4.00 U/g Hb) and the 60% level (3.82 U/g Hb), respectively are sensitive and specific resulting in a good efficiency of discrimination between deficient and normal males. For the female group the ROC cut-off (5.84 U/g Hb) seems better than the 60% level cut-off (3.88 U/g Hb) to discriminate between normal and heterozygote or homozygote women with higher Youden Index.
The establishment of the normal values for a population is important for a better evaluation of the assay result. The ROC curve analysis is an alternative method to determine the status of patients since it correlates DNA analysis and G6PD activity. |
---|---|
AbstractList | Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the commonest enzymopathy worldwide. The incidence depends essentially on the methods used for the assessment. In this respect, we attempted in this study to set cut-off values of G6PD activity to discriminate among normal, heterozygous, and deficient individuals using the World Health Organization (WHO) classification and the receiver operating characteristics (ROC) curve analysis.
Blood samples from 250 female and 302 male subjects were enrolled in this study. The G6PD activity was determined using a quantitative assay. The common G6PD mutations in Tunisia were determined using the amplification refractory mutation system (ARMS-PCR) method. The ROC curve was used to choice the best cut-off.
Normal G6PD values were 7.69±2.37, 7.86±2.39, and 7.51±2.35 U/g Hb for the entire, male, and female groups, respectively. Cut-off values for the total, male, and female were determined using the WHO classification and ROC curves analysis. In the male population, both cut-offs established using ROC curve analysis (4.00 U/g Hb) and the 60% level (3.82 U/g Hb), respectively are sensitive and specific resulting in a good efficiency of discrimination between deficient and normal males. For the female group the ROC cut-off (5.84 U/g Hb) seems better than the 60% level cut-off (3.88 U/g Hb) to discriminate between normal and heterozygote or homozygote women with higher Youden Index.
The establishment of the normal values for a population is important for a better evaluation of the assay result. The ROC curve analysis is an alternative method to determine the status of patients since it correlates DNA analysis and G6PD activity. Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the commonest enzymopathy worldwide. The incidence depends essentially on the methods used for the assessment. In this respect, we attempted in this study to set cut-off values of G6PD activity to discriminate among normal, heterozygous, and deficient individuals using the World Health Organization (WHO) classification and the receiver operating characteristics (ROC) curve analysis.BACKGROUNDGlucose-6-phosphate dehydrogenase (G6PD) deficiency is the commonest enzymopathy worldwide. The incidence depends essentially on the methods used for the assessment. In this respect, we attempted in this study to set cut-off values of G6PD activity to discriminate among normal, heterozygous, and deficient individuals using the World Health Organization (WHO) classification and the receiver operating characteristics (ROC) curve analysis.Blood samples from 250 female and 302 male subjects were enrolled in this study. The G6PD activity was determined using a quantitative assay. The common G6PD mutations in Tunisia were determined using the amplification refractory mutation system (ARMS-PCR) method. The ROC curve was used to choice the best cut-off.METHODSBlood samples from 250 female and 302 male subjects were enrolled in this study. The G6PD activity was determined using a quantitative assay. The common G6PD mutations in Tunisia were determined using the amplification refractory mutation system (ARMS-PCR) method. The ROC curve was used to choice the best cut-off.Normal G6PD values were 7.69±2.37, 7.86±2.39, and 7.51±2.35 U/g Hb for the entire, male, and female groups, respectively. Cut-off values for the total, male, and female were determined using the WHO classification and ROC curves analysis. In the male population, both cut-offs established using ROC curve analysis (4.00 U/g Hb) and the 60% level (3.82 U/g Hb), respectively are sensitive and specific resulting in a good efficiency of discrimination between deficient and normal males. For the female group the ROC cut-off (5.84 U/g Hb) seems better than the 60% level cut-off (3.88 U/g Hb) to discriminate between normal and heterozygote or homozygote women with higher Youden Index.RESULTSNormal G6PD values were 7.69±2.37, 7.86±2.39, and 7.51±2.35 U/g Hb for the entire, male, and female groups, respectively. Cut-off values for the total, male, and female were determined using the WHO classification and ROC curves analysis. In the male population, both cut-offs established using ROC curve analysis (4.00 U/g Hb) and the 60% level (3.82 U/g Hb), respectively are sensitive and specific resulting in a good efficiency of discrimination between deficient and normal males. For the female group the ROC cut-off (5.84 U/g Hb) seems better than the 60% level cut-off (3.88 U/g Hb) to discriminate between normal and heterozygote or homozygote women with higher Youden Index.The establishment of the normal values for a population is important for a better evaluation of the assay result. The ROC curve analysis is an alternative method to determine the status of patients since it correlates DNA analysis and G6PD activity.CONCLUSIONSThe establishment of the normal values for a population is important for a better evaluation of the assay result. The ROC curve analysis is an alternative method to determine the status of patients since it correlates DNA analysis and G6PD activity. Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the commonest enzymopathy worldwide. The incidence depends essentially on the methods used for the assessment. In this respect, we attempted in this study to set cut-off values of G6PD activity to discriminate among normal, heterozygous, and deficient individuals using the World Health Organization (WHO) classification and the receiver operating characteristics (ROC) curve analysis. Methods: Blood samples from 250 female and 302 male subjects were enrolled in this study. The G6PD activity was determined using a quantitative assay. The common G6PD mutations in Tunisia were determined using the amplification refractory mutation system (ARMS-PCR) method. The ROC curve was used to choice the best cut-off. Results: Normal G6PD values were 7.69±2.37, 7.86±2.39, and 7.51±2.35 U/g Hb for the entire, male, and female groups, respectively. Cut-off values for the total, male, and female were determined using the WHO classification and ROC curves analysis. In the male population, both cut-offs established using ROC curve analysis (4.00 U/g Hb) and the 60% level (3.82 U/g Hb), respectively are sensitive and specific resulting in a good efficiency of discrimination between deficient and normal males. For the female group the ROC cut-off (5.84 U/g Hb) seems better than the 60% level cut-off (3.88 U/g Hb) to discriminate between normal and heterozygote or homozygote women with higher Youden Index. Conclusions: The establishment of the normal values for a population is important for a better evaluation of the assay result. The ROC curve analysis is an alternative method to determine the status of patients since it correlates DNA analysis and G6PD activity. |
Author | Fredj, Sondes Hadj Toumi, Nourelhouda Ouali, Faida Daboubi, Rym Laouini, Naouel Siala, Hajer Becher, Meriam Bibi, Amina Sahli, Chaima Abdelhafidh Haloui, Sabrine Jouini, Latifa Messsaoud, Taieb |
Author_xml | – sequence: 1 givenname: Naouel surname: Laouini fullname: Laouini, Naouel organization: Faculty of Sciences of Bizerte, University of Carthage, Tunis, Tunisia – sequence: 2 givenname: Chaima Abdelhafidh surname: Sahli fullname: Sahli, Chaima Abdelhafidh organization: Biochemistry Laboratory, Children’s Hospital, Research Laboratory LR0SP03, Tunis, Tunisia – sequence: 3 givenname: Latifa surname: Jouini fullname: Jouini, Latifa organization: Biochemistry Laboratory, Children’s Hospital, Research Laboratory LR0SP03, Tunis, Tunisia – sequence: 4 givenname: Sabrine surname: Haloui fullname: Haloui, Sabrine organization: Biochemistry Laboratory, Children’s Hospital, Research Laboratory LR0SP03, Tunis, Tunisia – sequence: 5 givenname: Sondes Hadj surname: Fredj fullname: Fredj, Sondes Hadj organization: Biochemistry Laboratory, Children’s Hospital, Research Laboratory LR0SP03, Tunis, Tunisia – sequence: 6 givenname: Rym surname: Daboubi fullname: Daboubi, Rym organization: Biochemistry Laboratory, Children’s Hospital, Research Laboratory LR0SP03, Tunis, Tunisia – sequence: 7 givenname: Hajer surname: Siala fullname: Siala, Hajer organization: Biochemistry Laboratory, Children’s Hospital, Research Laboratory LR0SP03, Tunis, Tunisia – sequence: 8 givenname: Faida surname: Ouali fullname: Ouali, Faida organization: Biochemistry Laboratory, Children’s Hospital, Research Laboratory LR0SP03, Tunis, Tunisia – sequence: 9 givenname: Meriam surname: Becher fullname: Becher, Meriam organization: Hematology Laboratory, Children’s Hospital, Tunis, Tunisia – sequence: 10 givenname: Nourelhouda surname: Toumi fullname: Toumi, Nourelhouda organization: Hematology Laboratory, Children’s Hospital, Tunis, Tunisia – sequence: 11 givenname: Amina surname: Bibi fullname: Bibi, Amina organization: Laboratory of Biology, National Institute of Nutrition and Food Technology, Tunis, Tunisia – sequence: 12 givenname: Taieb surname: Messsaoud fullname: Messsaoud, Taieb organization: Biochemistry Laboratory, Children’s Hospital, Research Laboratory LR0SP03, Tunis, Tunisia |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28099116$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kb1rHDEQxUWwiT-SNmVYSJNGtkZa7UeRIjhfBoObq9IInTS6W6OVNtKuw_330d3ZEExSzRS_93gz74KchBiQkHfArkCCvDbGj5QzaCjjUrwi51CLltZCwMlhr2nTcDgjFzk_MAZS1u1rcsY71vcAzTn5-QVnTOMQ9DzEUEVXbfxiYkba0Gkb87TVM1YWtzub4gaDzliZZabRuepR-wVzNYRKV6slDHnQoZritPiD2Rty6rTP-PZpXpLVt6-rmx_07v777c3nO2pqLmcKwmjTOYA1YqN7yZ11glsDrrXoYG0dcuGk6Lhj2oLrZWs7w3rbgkM04pJ8PNpOKf4qeWY1Dtmg9zpgXLKCrgHZtrWEgn54gT7EJYUSTkHPWfmJgL5Q75-oZT2iVVMaRp126vlpBaiPgEkx54ROmWE-nDwnPXgFTO27Uftu1L4bte-myK5eyJ6d_yv4dBT81r6UZHGTll1Z_kr9T6GUHZQ7xB841aZo |
CitedBy_id | crossref_primary_10_1038_s41598_017_17667_6 crossref_primary_10_1186_s12887_022_03740_1 crossref_primary_10_1093_ajcp_aqaa040 crossref_primary_10_1108_NFS_02_2021_0053 crossref_primary_10_3923_pjbs_2021_409_423 crossref_primary_10_5858_arpa_2021_0276_CP crossref_primary_10_1016_j_jfma_2019_03_010 crossref_primary_10_4103_2305_0500_311609 |
Cites_doi | 10.1016/j.bcmd.2008.12.005 10.1371/journal.pone.0028357 10.1136/jms.7.1.46 10.1186/1475-2875-12-391 10.1111/j.1365-2141.1979.tb03774.x 10.1002/j.1460-2075.1986.tb04436.x 10.1111/j.1651-2227.2002.tb03120.x 10.1002/j.1460-2075.1995.tb00205.x 10.1016/j.ymgme.2005.05.008 10.1053/j.semperi.2011.02.010 10.1016/j.patbio.2012.03.005 10.4269/ajtmh.14-0194 10.1371/journal.pmed.1001339 10.1016/S0140-6736(08)60073-2 10.1002/iub.137 10.1182/blood-2007-04-077412 10.1016/j.siny.2009.10.007 10.1371/journal.pntd.0004457 10.1007/s11033-012-2124-8 10.1016/j.bcmd.2012.01.001 10.1007/s00769-004-0878-y |
ContentType | Journal Article |
Copyright | Copyright Walter De Gruyter & Company 2017 |
Copyright_xml | – notice: Copyright Walter De Gruyter & Company 2017 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QO 7T7 7TK 7U7 8FD C1K FR3 P64 7X8 |
DOI | 10.1515/cclm-2016-0253 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Biotechnology Research Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) Neurosciences Abstracts Toxicology Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Biotechnology Research Abstracts Technology Research Database Toxicology Abstracts Engineering Research Database Industrial and Applied Microbiology Abstracts (Microbiology A) Neurosciences Abstracts Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic Biotechnology Research Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry |
EISSN | 1437-4331 |
EndPage | 1201 |
ExternalDocumentID | 28099116 10_1515_cclm_2016_0253 10_1515_cclm_2016_02535581193 |
Genre | Journal Article |
GroupedDBID | --- 0R~ 0~D 29B 354 36B 4.4 53G 5GY 5RE AAAEU AABBZ AAFPC AAGVJ AAILP AALGR AAONY AAOQK AAOWA AAPJK AAQCX AARRE AASQH AAWFC AAXCG ABAOT ABAQN ABDRH ABFKT ABFQV ABIQR ABJNI ABLJU ABMIY ABPLS ABRDF ABRQL ABUVI ABWLS ABXMZ ABYBW ACDEB ACEFL ACGFS ACIWK ACMKP ACPMA ACPRK ACUND ACXLN ACYCL ACZBO ADDWE ADEQT ADGQD ADGYE ADOZN AECWL AEDGQ AEGVQ AEICA AEJTT AEKEB AENEX AEQDQ AERZL AEXIE AFBAA AFBDD AFBQV AFCXV AFGDO AFGNR AFQUK AFRAH AFYRI AGBEV AHOVO AHVWV AHXUK AIERV AIKXB AIWOI AJATJ AJHHK AKXKS ALMA_UNASSIGNED_HOLDINGS ALUKF ALYBR AMAVY ASYPN AZMOX BAKPI BBCWN BCIFA BWHEM CGQUA CS3 DU5 EBS EJD EMOBN F5P FSTRU HZ~ IY9 KDIRW N9A O9- OBC OBS OEB OES OHH OVD P2P PQQKQ QD8 RDG SA. SLJYH TEORI UK5 WTRAM AAYXX CITATION ABVMU CGR CUY CVF DBYYV ECM EIF NPM 7QO 7T7 7TK 7U7 8FD C1K FR3 P64 7X8 |
ID | FETCH-LOGICAL-c425t-13cac8f11bee6a952fdf32dc1f7def1bdfe23f5382f0ad1f957d8c09d71feec3 |
ISSN | 1434-6621 1437-4331 |
IngestDate | Fri Jul 11 02:15:36 EDT 2025 Mon Jun 30 03:03:26 EDT 2025 Wed Feb 19 02:00:07 EST 2025 Thu Apr 24 23:03:47 EDT 2025 Tue Jul 01 02:49:27 EDT 2025 Thu Jul 10 10:38:19 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Keywords | glucose-6-phosphate dehydrogenase G6PD cut-off values molecular diagnosis |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c425t-13cac8f11bee6a952fdf32dc1f7def1bdfe23f5382f0ad1f957d8c09d71feec3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
PMID | 28099116 |
PQID | 1920099319 |
PQPubID | 105421 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_1861577451 proquest_journals_1920099319 pubmed_primary_28099116 crossref_citationtrail_10_1515_cclm_2016_0253 crossref_primary_10_1515_cclm_2016_0253 walterdegruyter_journals_10_1515_cclm_2016_02535581193 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2017-7-26 |
PublicationDateYYYYMMDD | 2017-07-26 |
PublicationDate_xml | – month: 07 year: 2017 text: 2017-7-26 day: 26 |
PublicationDecade | 2010 |
PublicationPlace | Germany |
PublicationPlace_xml | – name: Germany – name: Berlin |
PublicationTitle | Clinical chemistry and laboratory medicine |
PublicationTitleAlternate | Clin Chem Lab Med |
PublicationYear | 2017 |
Publisher | De Gruyter Walter De Gruyter & Company |
Publisher_xml | – name: De Gruyter – name: Walter De Gruyter & Company |
References | (ref371) 2013; 40 (ref471) 2016; 10 (ref281) 2009; 42 (ref441) 2011; 35 (ref171) 2011; 35 (ref231) 2013; 12 (ref311) 2010 (ref491) 2011; 6 (ref341) 1986; 5 (ref411) 2009; 61 (ref291) 2012; 9 (ref71) 1986; 5 (ref391) 2016; 74 (ref361) 2012; 48 (ref211) 2010; 41 (ref331) 2010; 15 (ref121) 2016; 74 (ref191) 2005; 86 (ref501) 2013; 12 (ref381) 2013; 61 (ref21) 2012; 9 (ref461) 2005; 86 (ref111) 2013; 61 (ref51) 2008; 111 (ref321) 2008; 111 (ref531) 2000; 7 (ref201) 2016; 10 (ref181) 2014; 91 (ref101) 2013; 40 (ref61) 2010; 15 (ref261) 2000; 7 (ref81) 1998; 15 (ref241) 2004; 10 (ref431) 2005; 72 (ref481) 2010; 41 (ref131) 1979; 43 (ref151) 2010; 87 (ref521) 2002; 91 (ref401) 1979; 43 (ref271) 1995; 14 (ref41) 2010 (ref511) 2004; 10 (ref01) 1995; 14 (ref221) 2011; 6 (ref351) 1998; 15 (ref31) 2008; 371 (ref11) 2009; 42 (ref421) 2010; 87 (ref251) 2002; 91 (ref301) 2008; 371 (ref91) 2012; 48 (ref161) 2005; 72 (ref141) 2009; 61 (ref451) 2014; 91 |
References_xml | – volume: 42 start-page: 267 year: 2009 ident: ref281 article-title: The global prevalence of glucose-6-phosphate dehydrogenase deficiency: A systematic review and meta-analysis publication-title: Blood Cells Mol Dis doi: 10.1016/j.bcmd.2008.12.005 – volume: 6 start-page: e28357 year: 2011 ident: ref491 article-title: Performance of the CareStart™ G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening publication-title: PLoS One doi: 10.1371/journal.pone.0028357 – volume: 7 start-page: 46 year: 2000 ident: ref531 article-title: Glucose-6-phosphate dehydrogenase deficiency neonatal screening: preliminary evidence that a high percentage of partially deficient female neonates are missed during routine screening publication-title: J Med Screen doi: 10.1136/jms.7.1.46 – volume: 12 start-page: 391 year: 2013 ident: ref501 article-title: G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests publication-title: Malar J doi: 10.1186/1475-2875-12-391 – volume: 43 start-page: 465 year: 1979 ident: ref401 article-title: International Committee for Standardization in Haematology: Recommended screening test for glucose-6-phosphate dehydrogenase (G-6-PD) deficiency publication-title: Br J Haematol doi: 10.1111/j.1365-2141.1979.tb03774.x – volume: 41 start-page: 982 year: 2010 ident: ref481 article-title: G6PD enzyme activity in normal term Malaysian neonates and adults using a OSMMR2000-D kit with Hb normalization publication-title: Southeast Asian J Trop Med Public Health – start-page: 4474 volume-title: Oxford textbook of medicine year: 2010 ident: ref41 – volume: 5 start-page: 1849 year: 1986 ident: ref71 article-title: Structural analysis of the X-linked gene encoding human glucose 6-phosphate dehydrogenase publication-title: EMBO J doi: 10.1002/j.1460-2075.1986.tb04436.x – volume: 91 start-page: 107 year: 2002 ident: ref251 article-title: X-chromosome inactivation and human genetic disease publication-title: Acta Paediatr Suppl doi: 10.1111/j.1651-2227.2002.tb03120.x – volume: 5 start-page: 1849 year: 1986 ident: ref341 article-title: Structural analysis of the X-linked gene encoding human glucose 6-phosphate dehydrogenase publication-title: EMBO J doi: 10.1002/j.1460-2075.1986.tb04436.x – volume: 15 start-page: 439 year: 1998 ident: ref351 article-title: X chromosome inactivation patterns in normal females publication-title: Blood Cells Mol Dis – volume: 87 start-page: 69 year: 2010 ident: ref421 article-title: Neonatal screening of G6PD deficiency in Tunisia publication-title: Arch Inst Pasteur Tunis – volume: 14 start-page: 5209 year: 1995 ident: ref271 article-title: Targeted disruption of the housekeeping gene encoding glucose 6-phosphate dehydrogenase (G6PD): G6PD is dispensable for pentose synthesis but essential for defense against oxidative stress publication-title: EMBO J doi: 10.1002/j.1460-2075.1995.tb00205.x – volume: 86 start-page: 212 year: 2005 ident: ref461 article-title: Alternative DNA-based newborn screening for glucose-6-phosphate dehydrogenase deficiency publication-title: Mol Genet Metab doi: 10.1016/j.ymgme.2005.05.008 – volume: 14 start-page: 5209 year: 1995 ident: ref01 article-title: Targeted disruption of the housekeeping gene encoding glucose 6-phosphate dehydrogenase (G6PD): G6PD is dispensable for pentose synthesis but essential for defense against oxidative stress publication-title: EMBO J doi: 10.1002/j.1460-2075.1995.tb00205.x – volume: 35 start-page: 155 year: 2011 ident: ref441 article-title: Neonatal screening for glucose-6-phosphate dehydrogenase deficiency: biochemical versus genetic technologies publication-title: Semin Perinatol doi: 10.1053/j.semperi.2011.02.010 – volume: 74 start-page: 219 year: 2016 ident: ref391 article-title: Molecular identification of Gd A- and Gd B- G6PD deficient variants by ARMS-PCR in a Tunisian population publication-title: Ann Biol Clin – volume: 7 start-page: 46 year: 2000 ident: ref261 article-title: Glucose-6-phosphate dehydrogenase deficiency neonatal screening: preliminary evidence that a high percentage of partially deficient female neonates are missed during routine screening publication-title: J Med Screen doi: 10.1136/jms.7.1.46 – volume: 61 start-page: 64 year: 2013 ident: ref381 article-title: Three new mutations account for the prevalence of glucose 6 phosphate deshydrogenase (G6PD) deficiency in Tunisia publication-title: Pathol Biol doi: 10.1016/j.patbio.2012.03.005 – volume: 87 start-page: 69 year: 2010 ident: ref151 article-title: Neonatal screening of G6PD deficiency in Tunisia publication-title: Arch Inst Pasteur Tunis – volume: 35 start-page: 155 year: 2011 ident: ref171 article-title: Neonatal screening for glucose-6-phosphate dehydrogenase deficiency: biochemical versus genetic technologies publication-title: Semin Perinatol doi: 10.1053/j.semperi.2011.02.010 – volume: 91 start-page: 854 year: 2014 ident: ref451 article-title: Comparison of quantitative and qualitative tests for glucose-6-phosphate dehydrogenase deficiency publication-title: Am J Trop Med Hyg doi: 10.4269/ajtmh.14-0194 – volume: 9 start-page: e1001339 year: 2012 ident: ref21 article-title: G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: A geostatistical model-based map publication-title: PLoS Med doi: 10.1371/journal.pmed.1001339 – volume: 6 start-page: e28357 year: 2011 ident: ref221 article-title: Performance of the CareStart™ G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening publication-title: PLoS One doi: 10.1371/journal.pone.0028357 – volume: 9 start-page: e1001339 year: 2012 ident: ref291 article-title: G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: A geostatistical model-based map publication-title: PLoS Med doi: 10.1371/journal.pmed.1001339 – volume: 72 start-page: 1277 year: 2005 ident: ref161 article-title: Diagnosis and management of G6PD deficiency publication-title: Am Fam Physician – volume: 15 start-page: 439 year: 1998 ident: ref81 article-title: X chromosome inactivation patterns in normal females publication-title: Blood Cells Mol Dis – volume: 12 start-page: 391 year: 2013 ident: ref231 article-title: G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests publication-title: Malar J doi: 10.1186/1475-2875-12-391 – volume: 371 start-page: 64 year: 2008 ident: ref31 article-title: Glucose-6-phosphate dehydrogenase deficiency publication-title: Lancet doi: 10.1016/S0140-6736(08)60073-2 – volume: 61 start-page: 27 year: 2009 ident: ref141 article-title: Glucose-6-phosphate dehydrogenase laboratory assay: How, when, and why? publication-title: IUBMB Life doi: 10.1002/iub.137 – volume: 91 start-page: 854 year: 2014 ident: ref181 article-title: Comparison of quantitative and qualitative tests for glucose-6-phosphate dehydrogenase deficiency publication-title: Am J Trop Med Hyg doi: 10.4269/ajtmh.14-0194 – volume: 42 start-page: 267 year: 2009 ident: ref11 article-title: The global prevalence of glucose-6-phosphate dehydrogenase deficiency: A systematic review and meta-analysis publication-title: Blood Cells Mol Dis doi: 10.1016/j.bcmd.2008.12.005 – volume: 111 start-page: 16 year: 2008 ident: ref51 article-title: Glucose-6-phosphate dehydrogenase deficiency: A historical perspective publication-title: Blood doi: 10.1182/blood-2007-04-077412 – volume: 15 start-page: 148 year: 2010 ident: ref331 article-title: Glucose-6-phosphate dehydrogenase deficiency and severe neonatal hyperbilirubinemia: A complexity of interactions between genes and environment publication-title: Semin Fetal Neonatal Med doi: 10.1016/j.siny.2009.10.007 – volume: 41 start-page: 982 year: 2010 ident: ref211 article-title: G6PD enzyme activity in normal term Malaysian neonates and adults using a OSMMR2000-D kit with Hb normalization publication-title: Southeast Asian J Trop Med Public Health – volume: 74 start-page: 219 year: 2016 ident: ref121 article-title: Molecular identification of Gd A- and Gd B- G6PD deficient variants by ARMS-PCR in a Tunisian population publication-title: Ann Biol Clin – volume: 10 start-page: e0004457 year: 2016 ident: ref471 article-title: Assessment of point-of-care diagnostics for G6PD deficiency in malaria endemic rural Eastern Indonesia publication-title: PLoS Neglected Tropical Diseases doi: 10.1371/journal.pntd.0004457 – volume: 61 start-page: 64 year: 2013 ident: ref111 article-title: Three new mutations account for the prevalence of glucose 6 phosphate deshydrogenase (G6PD) deficiency in Tunisia publication-title: Pathol Biol doi: 10.1016/j.patbio.2012.03.005 – volume: 91 start-page: 107 year: 2002 ident: ref521 article-title: X-chromosome inactivation and human genetic disease publication-title: Acta Paediatr Suppl doi: 10.1111/j.1651-2227.2002.tb03120.x – volume: 72 start-page: 1277 year: 2005 ident: ref431 article-title: Diagnosis and management of G6PD deficiency publication-title: Am Fam Physician – volume: 86 start-page: 212 year: 2005 ident: ref191 article-title: Alternative DNA-based newborn screening for glucose-6-phosphate dehydrogenase deficiency publication-title: Mol Genet Metab doi: 10.1016/j.ymgme.2005.05.008 – volume: 371 start-page: 64 year: 2008 ident: ref301 article-title: Glucose-6-phosphate dehydrogenase deficiency publication-title: Lancet doi: 10.1016/S0140-6736(08)60073-2 – volume: 61 start-page: 27 year: 2009 ident: ref411 article-title: Glucose-6-phosphate dehydrogenase laboratory assay: How, when, and why? publication-title: IUBMB Life doi: 10.1002/iub.137 – volume: 43 start-page: 465 year: 1979 ident: ref131 article-title: International Committee for Standardization in Haematology: Recommended screening test for glucose-6-phosphate dehydrogenase (G-6-PD) deficiency publication-title: Br J Haematol doi: 10.1111/j.1365-2141.1979.tb03774.x – volume: 111 start-page: 16 year: 2008 ident: ref321 article-title: Glucose-6-phosphate dehydrogenase deficiency: A historical perspective publication-title: Blood doi: 10.1182/blood-2007-04-077412 – volume: 40 start-page: 851 year: 2013 ident: ref101 article-title: Glucose-6-phosphate dehydrogenase deficiency in Tunisia: molecular data and phenotype-genotype association publication-title: Mol Biol Rep doi: 10.1007/s11033-012-2124-8 – volume: 48 start-page: 154 year: 2012 ident: ref361 article-title: Glucose-6-phosphate dehydrogenase (G6PD) mutations database: review of the “old” and update of the new mutations publication-title: Blood Cells Mol Dis doi: 10.1016/j.bcmd.2012.01.001 – volume: 10 start-page: 27 year: 2004 ident: ref511 article-title: Performance evaluation of a G-6-PD assay employing an adapted error grid graph publication-title: Accred Qual Assur doi: 10.1007/s00769-004-0878-y – volume: 40 start-page: 851 year: 2013 ident: ref371 article-title: Glucose-6-phosphate dehydrogenase deficiency in Tunisia: molecular data and phenotype-genotype association publication-title: Mol Biol Rep doi: 10.1007/s11033-012-2124-8 – volume: 15 start-page: 148 year: 2010 ident: ref61 article-title: Glucose-6-phosphate dehydrogenase deficiency and severe neonatal hyperbilirubinemia: A complexity of interactions between genes and environment publication-title: Semin Fetal Neonatal Med doi: 10.1016/j.siny.2009.10.007 – volume: 48 start-page: 154 year: 2012 ident: ref91 article-title: Glucose-6-phosphate dehydrogenase (G6PD) mutations database: review of the “old” and update of the new mutations publication-title: Blood Cells Mol Dis doi: 10.1016/j.bcmd.2012.01.001 – volume: 10 start-page: e0004457 year: 2016 ident: ref201 article-title: Assessment of point-of-care diagnostics for G6PD deficiency in malaria endemic rural Eastern Indonesia publication-title: PLoS Neglected Tropical Diseases doi: 10.1371/journal.pntd.0004457 – volume: 10 start-page: 27 year: 2004 ident: ref241 article-title: Performance evaluation of a G-6-PD assay employing an adapted error grid graph publication-title: Accred Qual Assur doi: 10.1007/s00769-004-0878-y – start-page: 4474 volume-title: Oxford textbook of medicine year: 2010 ident: ref311 |
SSID | ssj0015547 |
Score | 2.2341673 |
Snippet | Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the commonest enzymopathy worldwide. The incidence depends essentially on the methods used for the... |
SourceID | proquest pubmed crossref walterdegruyter |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1193 |
SubjectTerms | Adolescent Adult Blood Chemical Analysis - standards Child Classification Correlation analysis cut-off values Dehydrogenase Dehydrogenases Deoxyribonucleic acid DNA Female G6PD Genotype Glucose Glucose 6 phosphate dehydrogenase Glucosephosphate dehydrogenase Glucosephosphate Dehydrogenase - blood Glucosephosphate Dehydrogenase - genetics Glucosephosphate Dehydrogenase Deficiency - blood Glucosephosphate Dehydrogenase Deficiency - genetics Heterozygote Humans Incidence Male Males molecular diagnosis Mutation Phosphates Polymerase chain reaction Reference Values Sampling methods Tunisia Young Adult |
Title | Determination of glucose-6-phosphate dehydrogenase cut-off values in a Tunisian population |
URI | https://www.degruyter.com/doi/10.1515/cclm-2016-0253 https://www.ncbi.nlm.nih.gov/pubmed/28099116 https://www.proquest.com/docview/1920099319 https://www.proquest.com/docview/1861577451 |
Volume | 55 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZKJ8F4mGBcVhjISEg8VIY49zyWMpimjRcKmniJfKWV2qbqEqHxwl_nOLHTyzoJeImqxLWjfJ-Pz_G5GKHXPJWw6saMJJEOSJj4gmRMeMTjGWe-hkUwNNnIF5_j06_h2WV02en8Xotaqkr-VvzamVfyP6jCPcDVZMn-A7Jtp3ADfgO-cAWE4fpXGH9wsSxO7bMB6CQmi3FxtRiDItmXanwtlwV0wkxoelWSQuu-KfJdx2L1WX9kXNpmoi_a07zWddahS54U7nC42uNg6WN89NsO-nNWVJP6rCiQ3kWl2iiOL2zcpGMPx2wyY_0Bl8Zjryey3ZU-a_96Dm-i2UpETuFJs4nNl24wu19B641Q31a7bmRsGCSrRC0rhJtavZZs6ZpEpbQ5QfGGqI_qqhhCTGfACWoiqaONhgDVYlYD76egBlO6VXG7XsPdoztozwc7w--ivcGn9yffWkcUaFuJrfUJA77bHM5UkrYdbKo1N2yV--jgZx3-INWPZXVdOnd7rcWMHqADa37gQcOlh6ij5ofo3tABe4juXlgsH6HvG_TChcY76IU36IUtvXBDLzyZY4YdvfCKXo_R6OPJaHhK7FEcRIBQLwkNBBOpppQrFbMs8rXUgS8F1YlUmnKplR9oWDxhejNJdRYlMhVeJhOqlRLBE9SdF3N1hLAnMxOHJX2ZsjDzQs55FkcyTWFpYZ7WPUTch8yFLVNvTkuZ5sZcBQxyg0FuMMgNBj30pm2_aAq03Nry2OGS20l8lYOBY4wkWIh66FX7GL658ZuxuSoqaJOC2g9mUkR76GmDZzuUw7-H4i2A18bY-TpRlBpuP7u1y-dofzV_jlG3XFbqBWjAJX9pWfoHIEu1zA |
linkProvider | Walter de Gruyter |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3fb9MwED5BJ7HxMGAMCAwwEhJPXmMncZLHMTYKrHsqaOIl8k860SVVmwiNv57zkkZlgxd4jhPbd2d_n3PnO4DXKjOIukLSNHERjVOuaS51SEOVK8kdgmDsbyOPT8Xoc_zxLDlbuwvjwyqN_bZoLus2Q-rQVLrxP8r6XAOIwEOtZxeoYOYDaJNoOK0vZrdhI4vxvDKAjYP3b4--9L4EBMyrEitxFFMhOOtSN978zO_QdINv3oXtH1cu7H58a0h0fA_0ag5tAMr3_aZW-_rntfSO_zfJ-7DdEVVy0FrWA7hlyx3YPFzVh9uBO-POLf8Qvr5bBdV4NZPKkS4Sngo6n1bL-RQZLTF2emkWFVosIifRTU0r54jPNm6X5Lwkkky8bx3tlcz7smK7MDk-mhyOaFe0gWpc_r60vZY6c4wpa4XME-6Mi7jRzKXGOqaMszxyuM2iIUjDXJ6kJtNhblLmrNXRIxiUVWmfAAlN7iN2DDeZjPMwVkrlIjF4ZI-4DJ0LgK7UVeguobmvqzEr_MEGBVh4ARZegIUXYABv-vbzNpXHX1vurbRfdEt6WSAV9nQat6wAXvWPUebewyJLWzXYJkOCiIQ6YQE8bq2m74pn-DZjIgBxzYzW-vjjcJIkY8izn_7riy9hczQZnxQnH04_PYMt7olJmFIu9mBQLxr7HGlVrV506-YXTP0fZA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB7BVipwKFBegQJGQuLkbuwkTnIsbZfyaMVhQYhL5CdbtSTRbiJUfj3j5qHSwgXOsWN7Zuz5nPkyA_BSZQa9rpA0TVxE45Rrmksd0lDlSnKHTjD2fyMfHomDT_G7L8nAJlz1tEpjvy3bs6bLkDo1lW79h7Ix1wB64KnWp99RwcwTaJNoWht3HdayGO8yE1jbefN6__MYSkB_eV5hJY5iKgRnfebGq2_53TNdgZu3YOPHeQR7nN4FRzS7DWpYQsc_OdluG7Wtf17K7vhfa7wDGz1MJTudXd2Fa7bchBu7Q3W4TVg_7IPy9-Dr3kCp8UomlSM9D54KWi-qVb1APEuMXZyZZYX2in6T6LahlXPE5xq3K3JcEknmPrKO1krqsajYfZjP9ue7B7Qv2UA1bn5f2F5LnTnGlLVC5gl3xkXcaOZSYx1TxlkeOTxk0QykYS5PUpPpMDcpc9bq6AFMyqq0j4CEJvd8HcNNJuM8jJVSuUgMXtgjLkPnAqCDtgrdpzP3VTVOC3-tQfkVXn6Fl1_h5RfAq7F93SXy-GvLrUH5Rb-hVwUCYQ-m8cAK4MX4GGXu4yuytFWLbTKEhwinExbAw85oxqF4hr0ZEwGIS1Z0YYw_TidJMoYo-_G_dnwO6x_3ZsWHt0fvn8BN7lFJmFIutmDSLFv7FDFVo571u-YX1KAeCw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Determination+of+glucose-6-phosphate+dehydrogenase+cut-off+values+in+a+Tunisian+population&rft.jtitle=Clinical+chemistry+and+laboratory+medicine&rft.au=Laouini%2C+Naouel&rft.au=Sahli%2C+Chaima+Abdelhafidh&rft.au=Jouini%2C+Latifa&rft.au=Haloui%2C+Sabrine&rft.date=2017-07-26&rft.eissn=1437-4331&rft.volume=55&rft.issue=8&rft.spage=1193&rft_id=info:doi/10.1515%2Fcclm-2016-0253&rft_id=info%3Apmid%2F28099116&rft.externalDocID=28099116 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1434-6621&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1434-6621&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1434-6621&client=summon |